Streetbeat News

Products Services

IMNN

The FDA has cleared IMUNON's IND application, allowing the company to begin human testing of its drug, IMNN-101.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:31 pm

DIS

NFLX

SONY

Sony Group Corp (NYSE:SONY) has updated its Bravia TV line with four new models, focusing on streaming content with advanced picture settings and AI features. The Bravia 9 is the flagship model, with prices starting at $599.99. These TVs are designed to enhance the home cinema experience, initially compatible with Amazon Prime Video. The update reflects the shift from traditional broadcast to streaming services, with streaming revenue expected to reach $165 billion by 2027. Sony's stock saw a slight increase of 0.15% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

April 18, 2024 | 12:30 pm

MULN

Mullen Automotive, Inc. has announced the production of its 500th commercial vehicle, marking a significant milestone for the company. This achievement highlights Mullen's growing capabilities in the electric vehicle (EV) sector and its commitment to expanding its presence in the commercial EV market.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:26 pm

SPNS

Sapiens International Corporation (NASDAQ: SPNS) announced the launch of IntegrateAI, a new feature in its DecisionAI portfolio that integrates machine learning models into decision models for the insurance industry. This release follows the ModelAI release and is part of Sapiens Decision's AI strategy to enhance decision automation. IntegrateAI allows non-technical users to incorporate machine learning models, reducing complexities and increasing operational efficiency. Sapiens plans to introduce more AI-based products, including ExtractAI and OptimizeAI, to support decision modeling. The company will showcase IntegrateAI at Insurance Innovators USA in Nashville, TN in April 2024.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:20 pm

AMRC

Ameresco, Inc. (NYSE:AMRC), a leading cleantech integrator, has been awarded an Energy Savings Performance Contract (ESPC) by Columbia County, Oregon, to upgrade and modernize the historic John Gumm building. The project includes enhancements to energy efficiency through upgrades to boilers, HVAC, ventilation, lighting, and other infrastructure, contributing to a larger effort to improve county facilities. This initiative underscores Columbia County's commitment to sustainability and functionality for its workforce and community.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:15 pm

QRHC

UNFI

Quest Resource Holding Corporation (QRHC) has entered into an agreement with United Natural Foods, Inc. (UNFI) to provide waste, recycling, and food waste diversion services. This partnership aims to support UNFI's operational improvements, cost-efficiencies, and sustainability goals. Quest's solutions, including their patented Quest Proganics®, are designed to achieve high diversion rates for organic waste and offer comprehensive data for ESG reporting.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:14 pm

MNPR

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company, announced its radiopharmaceutical program MNPR-101-Zr has been selected for presentation at the SNMMI 2024 Annual Meeting in Toronto. This event is a key platform for advancements in the radiopharma sector.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:13 pm

AUID

authID Inc. (NASDAQ:AUID) has been selected by the National Notarial Centralized Verification System (NNCVS) to deploy its biometric identity verification platform. This collaboration aims to enhance the security and efficiency of online notarization services by providing real-time identity assurance using advanced biometric and document-based verification methods. authID's technology will help combat fraud, deepfakes, and AI-generated attacks, ensuring a secure and seamless user experience for notaries and their clients nationwide.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:09 pm

BIVI

BioVie Inc. (NASDAQ:BIVI) announced its participation in the 12th Annual Alzheimer's & Parkinson's Drug Development Summit in Boston, where it will present data on NE3107, a drug candidate for neurological disorders. The presentations will detail NE3107's impact on DNA methylation related to aging and its potential in treating Alzheimer's and Parkinson's diseases. The USAN Council and WHO have approved 'bezisterim' as the generic name for NE3107.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:09 pm

NVAX

Novavax has announced an agreement to supply its updated COVID-19 vaccine to private healthcare providers in the United Kingdom. This move could potentially increase the company's vaccine distribution and sales in the UK.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:09 pm